Clinical Trial Update: Brimonidine for Intraoperative Hemostasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of brimonidine tartrate for intraoperative hemostasis in eyelid procedures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatochalasis of Eyelid
• Ectropion
• Entropion
• Ptosis

Drugs mentioned

• BRIMONIDINE TARTRATE (brimonidine tartrate)

Snippet

Sponsor: University of Louisville | Conditions: Dermatochalasis of Eyelid, Ptosis, Eyelid | Phase 4 | Status: WITHDRAWN